Fast Multiplex PCR of Bronchoalveolar Lavage for Antibiotic Stewardship in Ventilator Associated Pneumonia. A Multicenter, Randomized Controlled Study

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Ventilator-associated pneumonia (VAP) remains one of the main nosocomial infections acquired in the intensive care unit (ICU). VAP is pneumonia occurring 48 hours after intubation. Today, bronchoalveolar lavage (BAL) is used for microbiological diagnosis, with bacterial culture and antibiotic susceptibility results within 48 to 72 hours. Multiplex PCR can detect DNA of a number of bacteriae, as well as the presence of resistance genes. However, its clinical value in the ICU remains to be demonstrated. We think that the use of multiplex PCR with a panel adapted to the microbiology of VAP, could be an interesting method for clinicians in ICU.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adult patients, hospitalized in intensive care unit

• on mechanical ventilation for at least 48 hours

• Suspected VAP

• With an indication for bronchoalveolar lavage (BAL)

Locations
Other Locations
France
Damien JOLLY
RECRUITING
Reims
Contact Information
Primary
Antoine GOURY
agoury@chu-reims.fr
03 10 73 68 85
Time Frame
Start Date: 2025-03-06
Estimated Completion Date: 2026-10-06
Participants
Target number of participants: 265
Treatments
Experimental: intervention group
Active_comparator: control group
Related Therapeutic Areas
Sponsors
Leads: CHU de Reims

This content was sourced from clinicaltrials.gov